Sprague John M 4/A
4/A · T2 Biosystems, Inc. · Filed Mar 29, 2022
Insider Transaction Report
Form 4/AAmended
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-02-24−145,719→ 291,439 total→ Common Stock (145,719 underlying) - Tax Payment
Common Stock
2022-02-24$0.45/sh−55,008$24,688→ 142,350 total - Exercise/Conversion
Common Stock
2022-02-24+145,719→ 197,358 total
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 191,204.
- [F3]55,008 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F4]The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 136,196.
- [F5]On February 24, 2021 the reporting person was granted 437,158 RSU's that vest in three equal installments commencing on February 24, 2022.